Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The effectiveness of maternal immunization in preventing infant pertussis was first demonstrated in England, 1 year after the program using diphtheria-tetanus-5-component acellular pertussis-inactivated polio vaccine (dT5aP-IPV) was introduced in 2012. Vaccine effectiveness against laboratory-confirmed pertussis has been sustained >90% in the 3 years following its introduction, despite changing to another acellular vaccine with different antigen composition. Consistent with this, disease incidence in infants <3 months of age has remained low despite high activity persisting in those aged 1 year and older. Vaccine effectiveness against infant deaths was estimated at 95% (95% confidence interval, 79%-100%). Additional protection from maternal immunization is retained in infants who received their first dose of the primary series. There is no longer evidence of additional protection from maternal vaccination after the third infant dose. Although numbers are small and ongoing assessment is required, there is no evidence of increased risk of disease after primary immunization in infants whose mothers received maternal vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal vaccination with a pertussis-containing vaccine is now routinely recommended in several countries and has been shown to be safe and to result in high concentrations of antibody in the infant over the first 2 months of life (18–21).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739 · cited 6×
“matched to the general practice of the cases [10, 11].”
BackgroundMethodInfluentialSelf-citationSawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 722
Munoz, F. M., Bond, N. H., Maccato, M., Pinell, P., Hammill, H. A., Swamy, G. K., Walter, E. B., Jackson, L. A., Englund, J. A., Edwards, M. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.3633 · Cited by 489
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385 · cited 3×
“ceived vaccine at least 1 week prior to delivery, using both the screening method and case-control study approaches [10, 11], and this level of protection appears to have been sustained in the 3 years following the introduction of the program despite”
BackgroundMethodSelf-citationSafety of pertussis vaccination in pregnant women in UK: observational study
Donegan, K., King, B., & Bryan, P. (2014) · BMJ · doi:10.1136/bmj.g4219 · Cited by 281 · cited 1×
“servational study in the United Kingdom, which did not identify an increased risk for a range of maternal, fetal, and neonatal outcomes among almost 18 000 vaccinated pregnant women and their infants [12].”
BackgroundEstimation of Vaccine Effectiveness Using the Screening Method
FARRINGTON, C. P. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.4.742 · Cited by 261 · cited 1×
“Detailed methods have been previously described [10, 19].”
Eberhardt, C. S., Blanchard-Rohner, G., Lemaître, B., Boukrid, M., Combescure, C., Othenin-Girard, V., Chilin, A., Petre, J., de Tejada, B. M., & Siegrist, C.-A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw027 · Cited by 253
Bogoch, I. I., Creatore, M. I., Cetron, M. S., Brownstein, J. S., Pesik, N., Miniota, J., Tam, T., Hu, W., Nicolucci, A., Ahmed, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61828-6 · Cited by 235
Research works printed but not linked: 1
- Maertens, 2015, Pertussis vaccination of pregnant women: rationale for the actual recommendations in Belgium, Tijdschrift Voor Geneeskunde, 71, 497
Cited by
Items 201–287 of 287
Immink, M. M., Kemmeren, J. M., Broeders, L., Bekker, M. N., de Melker, H. E., Sanders, E. A. M., & van der Maas, N. (2023) · Vaccine · doi:10.1016/j.vaccine.2022.12.061 · Cited by 6
Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine
Garlasco, J., Bordino, V., Marengo, N., Rainero, E., Scacchi, A., Ditommaso, S., Giacomuzzi, M., Bert, F., & Zotti, C. M. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.052 · Cited by 5
Immink, M. M., Bekker, M. N., de Melker, H. E., Rots, N. Y., Sanders, E. A. M., & van der Maas, N. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06559-w · Cited by 5
The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
Godoy, P., & Calles, J. M. (2022) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2022.03.002 · Cited by 5
Pertussis Vaccination: The Challenges Ahead
Guiso, N., & von Koenig, C. H. W. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2592-0735 · Cited by 4
Puthanakit, T., Chokephaibulkit, K., Anugulruengkitt, S., Chaithongwongwatthana, S., Phongsamart, W., Wittawatmongkol, O., Rungmaitree, S., Tang, Y., Kerdsomboon, C., Yuwaree, V., et al. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004609 · Cited by 4
Pertussis Reinfection in an Adult: A Cause of Persistent Cough Not to Be Ignored
Koufakis, T., Paschala, A., & Siapardanis, D. (2017) · Case Reports in Infectious Diseases · doi:10.1155/2017/4786141 · Cited by 4
“Newborns are vulnerable to infection during the first weeks of their life, given that the quantity of maternal antibodies transferred is, inmost cases, insufficient to provide protection [11].”
BackgroundWesley, C., & Winckworth, L. C. (2021) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2020-321368 · Cited by 4
Brousseau, N., Angers-Goulet, M.-E., Bastien, R., Ye, L., Sadarangani, M., & Halperin, S. A. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.03.015 · Cited by 4
Pertussis vaccination in pregnancy in Canada: a cost-utility analysis
Abu-Raya, B., Coyle, D., Bettinger, J. A., Vaudry, W., Halperin, S. A., & Sadarangani, M. (2020) · CMAJ Open · doi:10.9778/cmajo.20200060 · Cited by 4
Improving vaccine coverage in adolescence and beyond
Falconer, M. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1394535 · Cited by 4
“The vaccine is now recommended to be administered from 16 weeks gestation and vaccine effectiveness against infant death is estimated at 95%.(9)”
BackgroundWang, H., Zheng, Y., de Groot, R., Yang, Y., Diavatopoulos, D. A., Chen, Y., de Jonge, M. I., & Deng, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.01.009 · Cited by 4
Skoff, T. H., Rubis, A. B., Kirley, P. D., Scherzinger, K., McMahon, M., McGuire, S. M., Kudish, K. S., Cieslak, P. R., Shang, N., & Hariri, S. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae655 · Cited by 3
Bednarek, S., Świątkowska-Freund, M., Szelc, R., Domieracka, P., Tworkiewicz, M., & Preis, K. (2025) · Vaccines · doi:10.3390/vaccines13050458 · Cited by 3
“%) was shown by the vaccine in terms of hospitalisation due to pertussis in infants up to the end of 2 months of age [17].”
Calvert, A., & Heath, P. T. (2017) · Medicine · doi:10.1016/j.mpmed.2017.09.015 · Cited by 3
Hempel, K., McDonald, W., Osgood, N. D., Fisman, D. N., Halperin, S. A., Crowcroft, N. S., Klein, N. P., Rohani, P., & Doroshenko, A. (2023) · Vaccine · doi:10.1016/j.vaccine.2022.12.071 · Cited by 3
Rapport 21-03. Il faut vacciner les femmes enceintes contre la grippe et contre la coqueluche
Buisson, Y., Bègué, P., & Grimprel, E. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.04.004 · Cited by 3
Loughnan, M., & Mehring-Le-Doare, K. (2020) · Springer eBooks · doi:10.1007/978-3-319-16999-6_828-1 · Cited by 3
Hall, J. M., Caution, K., Holt, K. J. A., Gupta, Y. A., Guo, M., Mir, U. Q., Skoff, T. H., Hariri, S., Pan, X. J., Worly, B. L., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2547732 · Cited by 2
Global variations in immunisation strategies against pertussis in infancy
Murphy, S. A., Kelly, A., & Kelly, D. F. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2562197 · Cited by 3
“The deaths of 14 infants in England in 2012 prompted an emergency maternal Tdap vaccination program to be implemented in the UK, the first of its kind in Europe, which proved extremely effective in protecting infants from pertussis [178].”
Saso, A., Fröberg, J., Jobe, H., Eleveld, M. J., Okoye, M. E., Kanteh, E., Arns, A. J., van Opzeeland, F. J., Kumado, M., Faal, A., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101219 · Cited by 2
van Roon, A. M., van Meijeren, D., de Gier, B., Wierik, M. T., & de Melker, H. E. (2026) · Eurosurveillance · doi:10.2807/1560-7917.es.2026.31.15.2500919 · Cited by 2
Tetanus, Diphtheria and Pertussis
Dudley, M. Z., Salmon, D. A., Halsey, N. A., Orenstein, W. A., Limaye, R. J., O’Leary, S. T., & Omer, S. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-94694-8_17 · Cited by 2
Impfen in der Schwangerschaft zum frühen Infektionsschutz für Neugeborene
Heininger, U. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-018-0629-5 · Cited by 2
GBS vaccines in the UK: a round table discussion
Thorn, N., Guy, R. L., Karampatsas, K., Powell, M., Walker, K. F., Plumb, J., Khalil, A. A., Greening, V., Eccleston, E., Trotter, C. L., et al. (2024) · F1000Research · doi:10.12688/f1000research.147555.1 · Cited by 2
Self-citationPertussis and Other Bordetella Infections
Cherry, J. D., & Heininger, U. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00129-1 · Cited by 2
Routine vaccinations during pregnancy: an update
Wilcox, C. R., Rowe, R., Mobley, D., Willcox, M. L., & Jones, C. E. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x708089 · Cited by 2
Heininger, U. (2020) · Der Pneumologe · doi:10.1007/s10405-020-00345-2 · Cited by 2
Calvert, A., Karampatsas, K., Andrews, N. J., England, A., Hallis, B., Jones, C. E., Khalil, A. A., Doaré, K. L., Matheson, M., Snape, M. D., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16767.1 · Cited by 2
Self-citationGül, S., Sönmez, C., Ayvaz, G., & Kılıç, S. (2021) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2021.06.010 · Cited by 2
The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
Godoy, P., & Calles, J. M. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.03.016 · Cited by 3
Immunobiological aspects of vaccines in pregnancy: Infant perspective
Wilcox, C. R., & Jones, C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814582-1.00004-8 · Cited by 1
Hsiao, A., Bartlett, J., FIREMAN, B. H., Zerbo, O., Hansen, J. R., Macina, D., & Klein, N. P. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.11.025 · Cited by 1
Maternal Immunization: Optimizing Passive Immunity in the Newborn
Michie, C. A. (2026) · Newborn · doi:10.5005/jp-journals-11002-0173 · Cited by 1
Preventive and Protective Properties of Pertussis Vaccines: Current Situation and Future Challenges
De-Simone, S. G., Provance, D. W., & Rocha da Silva, F. (2018) · InTech eBooks · doi:10.5772/intechopen.75055 · Cited by 1
Wolff, E., Aronsson, B., Markus, H., & Brouwers, L. (2019) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510065 · Cited by 1
การให้วัคซีนบาดทะยัก คอตีบ ไอกรน ในหญิงตั้งครรภ์
Limsiri, P., ฉายะจินดา, เ., ชัยทองวงศ์วัฒนา, ส., & ต่วนแวนา, ป. (2022) · Siriraj Medical Bulletin · doi:10.33192/smb.v15i1.252557 · Cited by 2
Faut-il vacciner les femmes enceintes françaises contre la coqueluche ?
Hattabi, H., Bouchez, C., Dubos, F., Martinot, A., Faure, K., Dessein, R., Bartolo, S., & Subtil, D. (2022) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2022.02.081 · Cited by 7
Vesikari, T., Maertens, K., & Finn, A. H. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-77173-7_6 · Cited by 1
(2017) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2017.311 · Cited by 1
Forsyth, K. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-55512-8.00044-2 · Cited by 1
Editorial, A. (2022) · Педиатрическая фармакология · doi:10.15690/pf.v19i3.2426 · Cited by 1
Vlkova, E., & Gospodinova, M. (2020) · Scripta Scientifica Medica · doi:10.14748/ssm.v51i1.5871 · Cited by 1
Correia, C. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.99.2018.tde-18052018-101733 · Cited by 3
Loughnan, M., & Mehring-Le-Doare, K. (2021) · Springer eBooks · doi:10.1007/978-3-319-19650-3_828 · Cited by 1
A mathematical model for pertussis transmission and vaccinationPreprint
Hounsell, R., Norman, J., Muloiwa, R., & Silal, S. P. (2026) · medRxiv · doi:10.64898/2026.03.16.26348473 · Cited by 1
A mathematical model for tetanus transmission and vaccinationPreprint
Hounsell, R., Norman, J., & Silal, S. P. (2026) · medRxiv · doi:10.64898/2026.03.16.26348506 · Cited by 1
Winter, K., & Harriman, K. H. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix028
Writers, A. M. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0471-1
“According to data from the 3-year period following the introduction of a national maternal immunization programme in England, the estimated vaccine effectiveness was[ 90% against laboratory-confirmed pertussis (regardless of type of dTaP/IPV used) and 95% against infant deaths, and there was no evidence that maternal…”
BackgroundMethodNo 357 – Immunisation pendant la grossesse
Castillo, E., & Poliquin, V. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.01.011
Immunization in Pregnancy: The Future for Neonatal Protection
Castillo, E., & Sadarangani, M. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.02.006
L'immunisation pendant la grossesse : l'avenir de la protection néonatale
Castillo, E., & Sadarangani, M. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.02.015
The role of national surveillance data in meningococcal conjugate vaccine programmes in England
Campbell, H. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32479680
Self-citationSood, A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108650434.001
Assessing Obstetrical and Perinatal Outcomes Associated with Maternal Tdap Immunization
Fakhraei, R. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24290
Laverty, M. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24323
Low Bordetella pertussis Antibody Seroprevalence Among Mothers and Infants
Kural, B., Boran, P., Karapınar, E. D., Gökçay, G., Eren, T., Badur, S., & Yılmaz, G. (2020) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.5222/bmj.2020.30502
Maertens, K., Edwards, K. M., & Leuridan, E. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814582-1.00009-7
Leuridan, E. E., Nunes, M. C., & Jones, C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814582-1.00016-4
Heininger, U. (2021) · Springer eBooks · doi:10.1007/978-3-030-77173-7_18
Gill, C. J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731988165.793546198
Vacunación en neonatos contra la enfermedad resurgente pertussis: un desafío, una estrategia
Aispuro, P. M. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/160442
Vigilancia epidemiológica de la tosferina en Cataluña 2011-2018
Carmona-Parcerisa, G., Ruiz-Mitjavila, L., Fernández-Gutiérrez, C., Jané-Checa, M., Mateo, A. M., & Ciruela, P. (2024) · Vacunas · doi:10.1016/j.vacun.2023.10.001
Whooping cough surveillance in Catalonia, 2011–2018
Carmona-Parcerisa, G., Ruiz-Mitjavila, L., Fernández-Gutiérrez, C., Jané-Checa, M., Mateo, A. M., & Ciruela, P. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacune.2024.02.002
La vaccination des femmes enceintes : un outil majeur de prévention pour les nourrissons
Walid, O., & Gagneux‐Brunon, A. (2024) · Médecine et Maladies Infectieuses Formation · doi:10.1016/j.mmifmc.2024.12.001
El desarrollo de las vacunas en la mejora de la salud infantil
Arribas, J. M. M. (2024) · Repositorio Institucional de la Universidad de Burgos (University of Burgos) · doi:10.36443/10259/10820
Immink, M. M., Bekker, M. N., de Melker, H. E., Rots, N. Y., Sanders, E. A. M., & van der Maas, N. (2021) · Figshare · doi:10.6084/m9.figshare.16569967
Widdershoven, V., Reijs, R. P., Eskes, A., Verhaegh-Haasnoot, A., & Hoebe, C. J. P. A. (2023) · Figshare · doi:10.6084/m9.figshare.22623689
Jones, C. E., Calvert, A., Southern, J., Matheson, M., Andrews, N. J., Khalil, A. A., Cuthbertson, H., Hallis, B., England, A., Heath, P. T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14746324
Self-citationJones, C. E., Calvert, A., Southern, J., Matheson, M., Andrews, N. J., Khalil, A. A., Cuthbertson, H., Hallis, B., England, A., Heath, P. T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14746327
Self-citationImmink, M. M., Bekker, M. N., de Melker, H. E., Rots, N. Y., Sanders, E. A. M., & van der Maas, N. (2021) · Figshare · doi:10.6084/m9.figshare.16569970
Resurgence of pertussis and strategies of B. pertussis to evade acellular vaccine induced immunity
Niinikoski, V. (2024) · UTUPub (University of Turku)
Terceiro, D., & Vietto, V. (2025) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v29i1.7199
Naninck, T. (2018) · theses.fr (ABES) · doi:10.70675/8c2cfa1bzc5ffz4e90z9911zc185d512798b · Cited by 1
Perinatal Infections and Vaccines
Tosto, V., Giardina, I., Brillo, E., Tsibizova, V., & Renzo, G. C. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_25
Teijsse, S. J., de Melker, H. E., Rots, N. Y., den Hartog, G., van Gageldonk, P. G. M., van der Molen, R. G., van Els, C. A. C. M., & van der Maas, N. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09212-z
de la Cueva, I. S., González-López, M., López, R. R., Macías, B. R., Jaramillo, S. O., Cots, M. B., Aldeán, J. Á., & Pérez, B. A. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2686489
“21,29,30 Future studies specifically designed and powered to evaluate the impact of maternal Tdap vaccination on infant immunogenicity would be of interest.”
Weerdt, L. D., Boisnard, F., & Maertens, K. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128915
Актуальность изменения стратегии вакцинации от коклюша для защиты детей первого года жизни
Прокопенко, А. В., Lomonosova, A. V., & Джепко, А. И. (2026) · Epidemiology and Vaccinal Prevention
Ru, L., Zhu, H., Ma, X., Abuduhaer, A., & Yan, M. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13984-2
“Data from the United Kingdom maternal immunization program demonstrated that antenatal pertussis vaccination reduced the risk of confirmed pertussis in young infants by approximately 90% [24].”
Prokopenko, A. V., Lomonosova, A. V., & Джепко, А. И. (2026) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2026-25-3-90-103
Time to rethink prevention of neonatal group B streptococcal disease
Teuscher, J. L., Lohrmann, F., Herting, E., Sugihara, F., Henneke, P., & Härtel, C. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01080-1
“The concept of diaplacental transfer of immunoglobulins particularly in the last trimester [ 155, 156] is already being utilized for vaccinations against pertussis [ 157, 158], SARS-CoV-2 [ 159 ], influenza [ 157 ], and tetanus [ 160].”
The resurgence of pertussis in Poland and Europe: Causes and vaccination strategies
Pyziak-Kowalska, K. A. (2026) · Przeglad Epidemiologiczny · doi:10.32394/pe/236465
“In an observational study in England, effectiveness in preventing confirmed pertussis in infants under three months of age was estimated at 91% (95% CI: 84-95%), and effectiveness in preventing infant deaths at 95% (95% CI: 79-100%; small number of events) (23,24).”
Ismail, S., Farnes, K. B., Patel, T., Belghiti, F. A. E., Brisse, S., Campbell, C., Campbell, H., Gabutti, G., González‐López, J. J., Knuutila, A., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101902
Self-citation
Metadata
- Authors
- Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N.
- Affiliations
- Public Health England (GB)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-12
- Volume
- 63
- Issue
- suppl 4
- Pages
- S236-S243
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5106626
- OpenAlex
- W2554060857
- Cited by
- 275
- References
- 20
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 10 · 2023: 23 · 2022: 21 · 2021: 54 · 2020: 38 · 2019: 34 · 2018: 39 · 2017: 26
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- acellular pertussis vaccine, vaccine effectiveness, infant pertussis prevention, infant mortality, vaccine safety, disease incidence, England
- MeSH terms
- Adult, England, Female, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Mortality, Population Surveillance, Vaccination, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Incidence, Outcome Assessment, Health Care, Immunization Programs, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.